Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America 3D Cell Culture Market, by Type
1.4.2 North America 3D Cell Culture Market, by Application
1.4.3 North America 3D Cell Culture Market, by End User
1.4.4 North America 3D Cell Culture Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansion
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2018, May – 2022, Oct) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun – 2022, Jun) Leading Players
Chapter 4. North America 3D Cell Culture Market by Type
4.1 North America Scaffold-based Market by Country
4.2 North America Scaffold-free Market by Country
4.3 North America Microfluidics-based Market by Country
4.4 North America Magnetic & Bioprinted Market by Country
Chapter 5. North America 3D Cell Culture Market by Application
5.1 North America Cancer & Stem Cell Research Market by Country
5.2 North America Drug Discovery & Toxicology Testing Market by Country
5.3 North America Tissue Engineering & Regenerative Medicine Market by Country
Chapter 6. North America 3D Cell Culture Market by End User
6.1 North America Pharmaceutical & Biotechnology Companies Market by Country
6.2 North America Research Institutes Market by Country
6.3 North America Cosmetic Industry Market by Country
6.4 North America Others Market by Country
Chapter 7. North America 3D Cell Culture Market by Country
7.1 US 3D Cell Culture Market
7.1.1 US 3D Cell Culture Market by Type
7.1.2 US 3D Cell Culture Market by Application
7.1.3 US 3D Cell Culture Market by End User
7.2 Canada 3D Cell Culture Market
7.2.1 Canada 3D Cell Culture Market by Type
7.2.2 Canada 3D Cell Culture Market by Application
7.2.3 Canada 3D Cell Culture Market by End User
7.3 Mexico 3D Cell Culture Market
7.3.1 Mexico 3D Cell Culture Market by Type
7.3.2 Mexico 3D Cell Culture Market by Application
7.3.3 Mexico 3D Cell Culture Market by End User
7.4 Rest of North America 3D Cell Culture Market
7.4.1 Rest of North America 3D Cell Culture Market by Type
7.4.2 Rest of North America 3D Cell Culture Market by Application
7.4.3 Rest of North America 3D Cell Culture Market by End User
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Acquisition and Mergers:
8.1.5.3 Geographical Expansions:
8.2 Merck Group
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Avantor, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Partnerships, Collaborations, and Agreements:
8.3.4.2 Acquisition and Mergers:
8.4 Corning Incorporated
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Lonza Group AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Geographical Expansions:
8.6 Mimetas B.V.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Product Launches and Product Expansions:
8.7 Insphero AG
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.7.2.2 Product Launches and Product Expansions:
8.8 Emulate, Inc.
8.8.1 Company Overview
8.9 Tecan Group Ltd.
8.9.1 Company Overview
8.10. CN Bio Innovations Ltd.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
8.10.2.2 Product Launches and Product Expansions:
8.10.2.3 Geographical Expansions:
Unique Offerings 